Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
The University of Texas MD Anderson Cancer Center · St. Vincent's University Hospital · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,800
total citations
- FWCI
- 106.51
- Percentile
- 100%
- References
- 37
Citations per year
Authors
16Topics & keywords
Topics
Keywords
- Nivolumab
- Medicine
- Irinotecan
- Microsatellite instability
- Colorectal cancer
- Internal medicine
- Oncology
- Clinical endpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.